arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Takeda Pharmaceutical Company Limited

TAK Health Care Biotechnology: Pharmaceutical Preparations
$16.50
▼ -1.4% Today
as of Aug 5, 16:54 ET
Last 30 days +4.63% Jun 29 → Aug 05
$15.81 $16.33 $16.85 $17.37 $17.89 Jun 29 Jul 07 Jul 14 Jul 22 Jul 29 Aug 05
Open
$15.51
High
$15.68
Low
$15.46
Volume
$4M
Avg Vol
$3M
Mkt Cap
$2.5B
P/E (TTM)
—
Beta
—
52w High
$18.90
52w Low
$12.99
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 0 ● 4 ▼ 0
Aug 5 · 22:10 PR Business Wire
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
Jul 30 · 20:01 PR GlobeNewswire
Keros Therapeutics to Receive Development Milestone Payment from Partner Takeda
Jul 30 · 12:03 MarketBeat
Takeda Pharmaceutical Q1 Earnings Call Highlights
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$13
$19
59% of range
Avg surprise (last 3)
+3.5%
Avg reaction (last 2)
-2.0%
50% positive
Latest IV / EM
35%
EM ±5.8% · $18 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.16$0.25$0.34$0.43$0.52 Actual $0.16Est $0.24Actual $0.52Est $0.47Actual $0.28Est $0.21 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $0.28 $0.21 +33.3% +75.0% +1.3% earnings
Wed Jul 30, 2025Jun/2025 $0.52 $0.47 +10.6% — — earnings
Thu May 8, 2025Mar/2025 $0.16 $0.24 -33.3% — -5.2% earnings

Implied volatility — last 90 days

26%87%149%210%272% Jun 07 — IV 62% · EM ±8.7%Jun 08 — IV 99% · EM ±13.0%Jun 09 — IV 135% · EM ±16.9%Jun 10 — IV 97% · EM ±11.5%Jun 11 — IV 63% · EM ±7.0%Jun 12 — IV 106% · EM ±10.8%Jun 15 — IV 149% · EM ±10.8%Jun 19 — IV 30% · EM ±6.7%Jun 22 — IV 29% · EM ±6.1%Jun 23 — IV 35% · EM ±7.1%Jun 24 — IV 34% · EM ±6.8%Jun 25 — IV 31% · EM ±6.1%Jun 26 — IV 27% · EM ±5.2%Jun 29 — IV 42% · EM ±7.4%Jun 30 — IV 37% · EM ±6.4%Jul 01 — IV 38% · EM ±6.4%Jul 02 — IV 66% · EM ±10.7%Jul 03 — IV 69% · EM ±10.7%Jul 06 — IV 51% · EM ±7.1%Jul 07 — IV 51% · EM ±6.8%Jul 08 — IV 79% · EM ±9.9%Jul 09 — IV 99% · EM ±11.7%Jul 13 — IV 272% · EM ±22.7%Jul 14 — IV 177% · EM ±12.8%Jul 15 — IV 252% · EM ±14.9%Jul 16 — IV 272% · EM ±11.3%Jul 20 — IV 31% · EM ±7.3%Jul 21 — IV 29% · EM ±6.8%Jul 22 — IV 27% · EM ±6.2%Jul 23 — IV 36% · EM ±8.0%Jul 24 — IV 27% · EM ±5.9%Jul 27 — IV 26% · EM ±5.4%Jul 28 — IV 29% · EM ±5.8%Jul 29 — IV 60% · EM ±11.9%Jul 30 — IV 30% · EM ±5.8%Jul 31 — IV 29% · EM ±5.6%Aug 03 — IV 31% · EM ±5.4%Aug 04 — IV 41% · EM ±7.1%Aug 05 — IV 35% · EM ±5.8%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,164.75-0.4%
JNJ
Johnson & Johnson
$624.1B $258.23+0.2%
ABBV
AbbVie Inc.
$454.8B $246.35+0.1%
MRK
Merck & Company, Inc.
$321.6B $129.20+0.7%
PM
Philip Morris International Inc
$299.3B $188.93-0.0%
NVS
Novartis AG
$297.9B $154.440.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in